Imagen de Portada

Validation of regression‐based change formulae for mild cognitive impairment and Alzheimer's disease

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Kevin Duff, Deborah Sevigny‐Resetco
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Longitudinal changes in the brain‐age gap in mild cognitive impairment and their relationships with neuropsychological functions and Alzheimer's disease biomarkers
por: Rachel R. Jin, et al.
Publicado: (2025)

Utilizing deep learning to predict Alzheimer's disease and mild cognitive impairment with optical coherence tomography
por: Jacqueline Chua, et al.
Publicado: (2025)

Diagnosing Alzheimer's disease: Which dementia screening test to use in elderly Puerto Ricans with mild cognitive impairment and early Alzheimer's disease?
por: María A. Rodríguez‐Santiago, et al.
Publicado: (2024)

Retinal vascular biomarkers in mild cognitive impairment and Alzheimer's disease: a comprehensive review and meta‐analysis
por: Sunu Mathew, et al.
Publicado: (2025)

Non‐Alzheimer's amnestic mild cognitive impairment with medial temporal hypometabolism
por: Sebastiaan De Keersmaecker, et al.
Publicado: (2024)

Allostatic load dynamics, Alzheimer's disease biomarkers, and progression in individuals with mild cognitive impairment: findings from the Alzheimer's Disease Neuroimaging Initiative
por: Juliana N. Souza‐Talarico, et al.
Publicado: (2025)

Eye tracking as a diagnostic tool in Alzheimer's disease, mild cognitive impairment, and related dementias: a systematic review
por: Gustavo Luis Verón, et al.
Publicado: (2025)

Real‐world use of diagnostic tests for mild cognitive impairment, Alzheimer's disease, and other dementias in Medicare fee‐for‐service beneficiaries
por: Jessie T. Yan, et al.
Publicado: (2025)

Excessive sleep is associated with worse cognition, cognitive decline, and dementia in mild cognitive impairment
por: Marieclaire Overton, et al.
Publicado: (2025)

Task‐evoked pupillary responses as potential biomarkers of mild cognitive impairment
por: Julius Opwonya, et al.
Publicado: (2024)

Prevalence and predictors of diagnosed mild cognitive impairment among Medicare beneficiaries
por: Elyse Couch, et al.
Publicado: (2025)

The prognosis of mild cognitive impairment: A systematic review and meta‐analysis
por: Simone Salemme, et al.
Publicado: (2025)

Correction to “The prognosis of mild cognitive impairment: A systematic review and meta‐analysis”
Publicado: (2025)

Risk prediction of mild cognitive impairment using electronic health record data
por: Gang Li, et al.
Publicado: (2025)

Alzheimer's disease neuropathology and longitudinal change in subjective cognitive complaints
por: Alisa Bannerjee, et al.
Publicado: (2025)

Clinical performance of the fully automated Lumipulse plasma p‐tau217 assay in mild cognitive impairment and mild dementia
por: Adam H. Dyer, et al.
Publicado: (2025)

Classifying mild cognitive impairment from normal cognition: fMRI complexity matches tau PET performance
por: Kay Jann, et al.
Publicado: (2025)

Alzheimer's disease cerebrospinal fluid biomarkers and kidney function in normal and cognitively impaired older adults
por: Ihab Hajjar, et al.
Publicado: (2024)

Associations of plasma phosphorylated tau217 with cognitive impairment and brain microstructural alterations in Alzheimer's disease
por: Miguel Ángel Rivas‐Fernández, et al.
Publicado: (2026)

The impact of mild cognitive impairment on healthcare utilization and costs: A UK Biobank study
por: Craig Ritchie, et al.
Publicado: (2025)

Plasma amyloid‐β oligomerization tendency as a potential predictor for conversion from mild cognitive impairment to Alzheimer's dementia: Findings from the GMCII cohort
por: Yuhan Xie, et al.
Publicado: (2025)

Reversal of the concreteness effect can be detected in the natural speech of older adults with amnestic, but not non‐amnestic, mild cognitive impairment
por: Luwen Cao, et al.
Publicado: (2024)

Divergent effects of age on imaging‐based ATN biomarkers and cognition in Alzheimer's disease
por: Lars Frings, et al.
Publicado: (2025)

Delphi consensus guidelines for the use of striatal dopaminergic imaging and cardiac metaiodobenzylguanidine (MIBG) scintigraphy for the diagnosis of dementia and mild cognitive impairment with Lewy bodies
por: Paul C. Donaghy, et al.
Publicado: (2026)

The classification of mild cognitive impairment or healthy ageing improves when including practice effects derived from a semantic verbal fluency task
por: Felix Dörr, et al.
Publicado: (2025)

Relationship of plasma biomarkers to digital cognitive tests in Alzheimer's disease
por: Sofia Toniolo, et al.
Publicado: (2024)

Fixel‐based analysis and free‐water metrics in subjective cognitive decline and cognitive impairment no dementia
por: Zheng Long Lee, et al.
Publicado: (2026)

Toward the right treatment at the right time: Modeling the trajectory of cognitive decline to identify the earliest age of change in people with Alzheimer's disease
por: R. Asaad Baksh, et al.
Publicado: (2024)

Amyloid accumulation, brain atrophy, and cognitive decline in emergent Alzheimer's disease
por: Ying Xia, et al.
Publicado: (2025)

Cognitive dispersion is related to subtle objective daily functioning changes in older adults with and without cognitive impairment
por: Alyssa N. De Vito, et al.
Publicado: (2024)

Sex‐ and age‐specific effect of known type 2 diabetes mellitus on incident mild cognitive impairment five years later: Results from the population‐based Heinz Nixdorf Recall study
por: Anna Lena Platzbecker, et al.
Publicado: (2025)

Association of latent factors of neuroinflammation with Alzheimer's disease pathology and longitudinal cognitive decline
por: Stefan J. Teipel, et al.
Publicado: (2024)

Identifying cognitive test scores associated with early tau burden in Alzheimer's disease
por: Caitlin M. Terao, et al.
Publicado: (2025)

Longitudinal changes in functional capacity in frontotemporal dementia and Alzheimer's disease
por: David Foxe, et al.
Publicado: (2024)

Sensory changes in preclinical, prodromal, and clinical Alzheimer's disease and related dementias
por: Willa D. Brenowitz, et al.
Publicado: (2026)

Clinical classification of memory and cognitive impairment with multimodal digital biomarkers
por: Russell Banks, et al.
Publicado: (2024)

Cochlear dysfunction as an early biomarker of cognitive decline in normal hearing and mild hearing loss
por: Vicente Medel, et al.
Publicado: (2024)

Midlife sensory and motor functions improve long‐term predictions of cognitive decline and incidence of cognitive impairment
por: Carla R. Schubert, et al.
Publicado: (2024)

Rest‐activity rhythm characteristics associated with lower cognitive performance and Alzheimer's disease biomarkers in midlife women
por: Alexandra Paget‐Blanc, et al.
Publicado: (2025)

Artificial intelligence detection of cognitive impairment in older adults during walking
por: Shuichi P. Obuchi, et al.
Publicado: (2024)